cannot slap them with economic restrictions that really make it very difficult then for the next time a country to come forward and say, hey, we ve got a problem here. that s something we ve got to be thinking about as a global public health community and beyond. zeke, i think you ve been talking about this issue that the cdc s ability to surveil is not as good as it should be or could be. how s it looking these days? it s looking better than a year ago, but it s still not up to snuff. we should be surveilling at least 20 and maybe 30 or 40% of all positive cases and doing genetic surveillance on that. as dr. shah said, not in a patchwork of large cities with good academic centers, but across the country. and we should not just be testing those seriously ill that come to the hospital, but all the tests, whether they re